LYB: The Cleaner Hormuz Trade — Pending MENA Verification

Trade summary. LYB, RSI 37, prints Q1 in six days (May 1). Cross-ticker corroboration of a coordinated US ethane petrochemical pricing wave makes LYB a cleaner expression than DOW. Estimated 6-month Sharpe 0.7-0.9 (annualized α ≈40%, vol ≈50%). Edge directionally clear; magnitude ≈10-20pp over 6 months relative to options-implied distribution. Memo is conditional on verifying LYB has no material Saudi/Iran/Qatar JV exposure analogous to DOW's Sadara drag. Do not enter until 10-K segment/geography is checked.

Why Now: Petrochemical Lag, Not Tanker Lag

Tankers were a Day-1 Hormuz trade — CATALYST half-life of weeks, alpha decayed daily after the blockade was priced. The petrochemical pricing wave is different. Physical disruption began February 28; contract repricing happens at quarter boundaries; financials don't show it until Q2 prints in late July. DOW's Q1 EBITDA beat ($873M vs $750M guided) and "rapid positive momentum" forward language landed two weeks AFTER the tanker trade was killed by blockade fade. The wave is independent of WTI tape — it's a 3-6 month flow-through from concurrent supply removal (Sadara at zero revenue, SABIC force majeure on five product lines, Asian naphtha cracker hardware constraint), not a function of where oil prices print today.

The Coordination Signal

Four producers announced coordinated +30c/lb polyethylene increases for April: DOW, LYB, ExxonMobil, Nova. SABIC declared force majeure March 26-27 across MMA, MEG, DEG, styrene, methanol — five product lines, not just PE. ACC reported a March PVC sales record. LYB CFO at the JP Morgan conference: "demand everywhere... healthy demand for US product out of Europe, Latin America and Africa due to supply disruptions in the Middle East." Two CFOs at two different companies, weeks apart, framing the same way ("every region" / "everywhere"). Sell-side covers each name in isolation; the coordination doesn't aggregate up to a research note.

Why LYB and Not DOW

DOW is a doorway state — Sadara $500M probable Q2 cash call (management language: "probable"), $3.7B June 15 debt cliff, two rating agencies one notch from junk with Negative outlook, active securities class action, July 1 CEO transition. The pricing wave benefit is real for DOW, but it gets absorbed into Q2 EBITDA against a Sadara cash hit and credit overhang. DOW already moved +8.6% on the Q1 beat; the optionality is muddier.

LYB has none of those drags. It sits at RSI 37, -10% one month, with term structure inverted (58.5% near IV vs 51.4% far) — market positioned for binary outcome at the print, with $90 call OI of 4,769 contracts (institutional "if it works" positioning) and today's call volume running 2× put volume. RVOL 0.54x suggests forced/uninformed selling. The CFO has already telegraphed the thesis at JPM. The information is public; the price hasn't caught it.

Pricing the Gap

Bull (35%): pricing wave fully materializes Q2, EBITDA ramps to $4.5-5B run-rate, +30% to +43% to $90-100 (RBC PT $91 already raised Apr 10). Base (35%): partial materialization, +10% to +20%. Bear (20%): Hormuz partial reopening or downstream demand destruction, -5% to -15%. Tail bull (10%): Hormuz extended + capacity rationalization compounds, +50% to +65%.

Probability-weighted: ~+20% over 6 months. Options-implied distribution (51.4% IV, sell-side average PT zone) suggests +5-8%. The two-stage Stage 1 (May 1 print) → Stage 2 (Q2 print) tree is approximate — Stage 1 outcome conditions Stage 2 probabilities, and we haven't built the full conditional tree.

Edge range: roughly 10-20 percentage points over 6 months. Direction high confidence; magnitude is sensitive to how option deltas map to actual probability beliefs (skew-dependent), so resist a point estimate.

The asymmetry is real but not 6×. Bull-leaning scenarios (45% probability mass, +37% to +57% returns) dominate the bear scenario (20% at -10%). The 35% base case at +15% is the modal outcome.

Idio% — The Accounting

LYB shows 46% idio variance. Per Paleologo, that's ≈29% IR degradation vs a pure idio expression — material. The thesis intentionally accepts this: the trade has edge on factors (Hormuz CATALYST + US ethane DEMAND), not on idio alpha alone. Factor exposure with quantifiable thesis is α, not unwanted β — but only if the factor edge more than compensates for the IR drag. Rough math: pure-idio expected Sharpe ≈1.2 at this conviction level; factor-loaded expression at 0.85; haircut ≈30%, in line with the framework. Trade is still attractive but it's not a pure idio shot — it's a sector-factor-loaded expression with a vehicle selection alpha overlay.

Risks (Ranked)

1. LYB MENA exposure unverified. Trade kill switch. This memo cannot recommend capital commitment until checked. Estimated 1-2 hour task to read 10-K segment/geography note and equity affiliates.
2. Hormuz diplomatic breakthrough in next 30 days (≈20%). CATALYST decay, but DEMAND factors (Europe shutdowns, China VAT) persist independently.
3. LYB Q1 print cautious forward language (≈20%). CFO retreats from JPM framing → IV crush dominates, -5 to -10%.
4. Demand destruction at downstream (≈25%). Pricing actions don't stick on auto, construction, packaging.
5. Sadara restart announced (≈45% by Sep 30). Compresses pricing wave duration.

Catalysts

• May 1 (6 days): LYB Q1 2026 earnings — Stage 1 binary
• June 15: Sadara $3.7B principal debt cliff — forced timing event
• Late July: Q2 earnings across DOW/LYB/WLK/OLN — Stage 2 resolution

What Would Change Our Mind

LYB 10-K shows material Saudi/Iran JV equity or feedstock exposure → kill, shift to WLK. LYB Q1 print: "supply uncertainty" / cautious forward language without pricing momentum → exit at stop. Hormuz ceasefire announced before May 1 → edge compresses meaningfully; reassess. LYB Q2 EBITDA < Q1 EBITDA when reported → pricing wave failed at the cleanest vehicle, broader thesis questioned.

Evidence